(Q31026691)

28 June 2017

1 reference

title

Behaviour, cognition and epilepsy (English)

1 reference

28 June 2017

A P Aldenkamp

1

1 reference

PubMed ID

16359429

28 June 2017

N Bodde

series ordinal

2

1 reference

28 June 2017

1 January 2005

1 reference

Acta neurologica Scandinavica. Supplementum

28 June 2017

1 reference

28 June 2017

182

1 reference

28 June 2017

19-25

1 reference

Memory complaints in epilepsy: correlations with cognitive performance and neuroticism

28 June 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00523.X

Neuropsychological effects of epilepsy and antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00523.X

Antiepileptic drugs and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00523.X

Neuropsychological aspects of type of epilepsy and etiological factors in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00523.X

Posttraumatic epilepsy: neuroradiologic and neuropsychological assessment of long-term outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00523.X

Cognitive outcome of children with epilepsy and malformations of cortical development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00523.X

Neuropsychological characteristics of the syndrome of mesial temporal lobe epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00523.X

Degree of left hippocampal atrophy correlates with severity of neuropsychological deficits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00523.X

Lennox-Gastaut syndrome: potential mechanisms of cognitive regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00523.X

The Landau-Kleffner syndrome: increased understanding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00523.X

Cognitive outcomes and predictive factors in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00523.X

The relationship between quantitative MRI and neuropsychological functioning in temporal lobe epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00523.X

Behavioral Aspects of Frontal Lobe Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00523.X

Language dominance in neurologically normal and epilepsy subjects: a functional MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00523.X

Quantitative fMRI assessment of the differences in lateralization of language-related brain activation in patients with temporal lobe epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00523.X

Lessons for neuropsychology from functional MRI in patients with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00523.X

Identifying regional activity associated with temporally separated components of working memory using event-related functional MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00523.X

Cognitive side effects of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00523.X

Prognostic factors affecting long-term retention of topiramate in patients with chronic epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00523.X

Psychomotor impairment and anticonvulsant therapy in adult epileptic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00523.X

Postmarketing experience with topiramate and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00523.X

A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00523.X

Effects of topiramate on cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00523.X

Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00523.X

Topiramate increases cerebral GABA in healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00523.X

Topiramate rapidly raises brain GABA in epilepsy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00523.X

A Systematic Review of the Effects of Lamotrigine on Cognitive Function and Quality of Life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00523.X

10.1111/J.1600-0404.2005.00523.X

21 January 2018

Identifiers

DOI

0 references

Fatcat ID

release_2qcl7xer5ba3rnqv3uefg5soke

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2qcl7xer5ba3rnqv3uefg5soke

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

16359429

1 reference

PubMed ID

16359429